Evidence map›Paper›PMID 32582805›Full record

ArticleReports of biochemistry & molecular biology2020

The Gene Expression Profile and DNA Methylation Pattern of CDH1 and DNMT1 Genes in Acute Promyelocytic Leukemia (APL).

Sanaz Zebardast, Mehdi Sahmani, Saeed Mohammadi, Farshad Foroughi, Ali Dehghani Fard, Zahra Mohammadi, Sahar Khojastepour, Mehdi Azad

Open access · greenAbstract read
In one paragraph

Article in Reports of biochemistry & molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. ExploringReports of biochemistry & molecular biology · 2025
    Article
  3. Article
  4. Exploring the nexus of nuclear receptors in hematological malignancies.Cellular and molecular life sciences : CMLS · 2024
    Review
  5. Article
  6. Review
  7. DNMT1 Gene Expression in Patients withTheScientificWorldJournal · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sanaz ZebardastCellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Mehdi SahmaniDepartment of Biochemistry, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Saeed MohammadiHematology-Oncology and stem cell transplantation research center, Tehran university of medical sciences, Tehran, Iran.
Farshad ForoughiDepartment of Immunology, Faculty of Allied Medicine, Qazvin university of Medical Sciences, Qazvin, Iran.
Ali Dehghani FardGholhak laboratory of Tehran, Iran.
Zahra MohammadiCellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Sahar KhojastepourCellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Mehdi AzadDepartment of Medical laboratory sciences, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Qazvin University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDNA methylation is an epigenetic modification that has the ability to alter gene expression and function. These epigenetic changes have been associated with the development of cancer. Previous research has found that DNA methylation patterns can predict disease prognosis for patients with Acute Promyelocytic Leukemia (APL). The role of DNMT1 and CDH1 in regulating the extension of cells are studied in this study.

methodsDNA was extracted from peripheral blood samples of APL patients and treated with bisulfite. DNMT1 and CDH1 gene promoter methylation was subsequently analyzed using methylation-specific PCR (MSP). Real-time PCR was used to measure the expression level of DNMT1 and CDH1 genes.

resultsPartial methylation of the CDH1 gene promoter was detected in 20% of APL patients and an unmethylated status was detected in 80% of patient samples. Additionally, an unmethylated status in the DNMT1 gene promoter was detected in 100% of APL patient samples.

conclusionOur study found the CDH1 gene promoter to be unmethylated in almost all APL patients, while the DNMT1 promoter was unmethylated in all APL patients. Furthermore, we observed an increase in both CDH1 and DNMT1 gene expression in APL patients compared to healthy controls. These findings suggest that DNMT1 may not have a specific role in inhibiting CDH1 gene expression in APL. Applying higher resolution techniques would help to better uncover the DNA methylation patterns in patients with APL. Further research is required to determine the role of DNA methylation and CDH1 and DNMT1 gene expression in APL.

Indexed as

Acute Promyelocytic LeukemiaCDH1DNMTPromoter Methylation

Identifiers

PMID32582805
PMCPMC7275828
OpenAlexW3026159436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.